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Abstract
Background: Paediatric fever is a common cause of emergency department (ED) attendance. A lack of prompt and
definitive diagnostics makes it difficult to distinguish viral from potentially life-threatening bacterial causes, necessitating a
cautious approach. This may result in extended periods of observation, additional radiography, and the precautionary use
of antibiotics (ABs) prior to evidence of bacterial foci. This study examines resource use, service costs, and health
outcomes.
Methods: We studied an all-year prospective, comprehensive, and representative cohort of 6518 febrile children
(aged < 16 years), attending Alder Hey Children’s Hospital, an NHS-affiliated paediatric care provider in the North
West of England, over a 1-year period. Performing a time-driven and activity-based micro-costing, we estimated
the economic impact of managing paediatric febrile illness, with focus on nurse/clinician time, investigations,
radiography, and inpatient stay. Using bootstrapped generalised linear modelling (GLM, gamma, log), we identified the
patient and healthcare provider characteristics associated with increased resource use, applying retrospective case-note
identification to determine rates of potentially avoidable AB prescribing.
Results: Infants aged less than 3 months incurred significantly higher resource use than any other age group, at £1000.28
[95% CI £82.39–£2993.37] per child, (p < 0.001), while lesser experienced doctors exhibited 3.2-fold [95% CI 2.0–5.1-fold]
higher resource use than consultants (p < 0.001). Approximately 32.4% of febrile children received antibiotics, and 7.1%
were diagnosed with bacterial infections. Children with viral illnesses for whom antibiotic prescription was potentially
avoidable incurred 9.9-fold [95% CI 6.5–13.2-fold] cost increases compared to those not receiving antibiotics, equal to an
additional £1352.10 per child, predominantly resulting from a 53.9-h increase in observation and inpatient stay
(57.1 vs. 3.2 h). Bootstrapped GLM suggested that infants aged below 3 months and those prompting a respiratory rate
‘red flag’, treatment by lesser experienced doctors, and Manchester Triage System (MTS) yellow or higher were statistically
significant predictors of higher resource use in 100% of bootstrap simulations.
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Conclusion: The economic impact of diagnostic uncertainty when managing paediatric febrile illness is significant, and
the precautionary use of antibiotics is strongly associated with increased costs. The use of ED resources is highest
among infants (aged less than 3 months) and those infants managed by lesser experienced doctors, independent of
clinical severity. Diagnostic advances which could increase confidence to withhold antibiotics may yield considerable
efficiency gains in these groups, where the perceived risks of failing to identify potentially life-threatening bacterial
infections are greatest.
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Background
Fever is a common cause of presentation to paediatric
emergency departments (EDs) [1], accounting for ~ 20%
of all visits [2], but despite its frequent occurrence, the
aetiology of fever is diverse [3]. Most children with fever
will suffer from self-limiting viral illnesses; however,
viral, bacterial, and severe bacterial infections (SBIs) may
result in almost identical clinical presentations in in-
fants, making diagnosis based on presentation, history,
and clinical judgement alone a difficult task.
While a clear focus of bacterial infection may be present
with presentations of acute otitis media (AOM) or urinary
tract infection (UTI), occult bacteremia can also occur in
children who appear otherwise well, and fever without
focus is a common presentation, particularly so in those
aged < 36months [4–6]. However, occurring in as few as
1% of febrile children [4, 5], these ‘hidden’ bacterial infec-
tions represent a needle in the haystack, and the challenge
for clinicians is to accurately identify children at risk of
bacterial infections. While it is possible that they may re-
solve spontaneously, for those in whom they do not,
life-threatening and potentially life-changing complica-
tions can develop [4, 7, 8], with adverse outcomes in each
survivor of severe meningococcal disease resulting in life-
long treatment costs of ~ £1.3m [9].
As a result, a cautious stepped approach to the man-
agement of the febrile child is common, characterised by
extended periods of observation, investigations, radiog-
raphy, and the precautionary use of antibiotics, often
prior to definitive evidence of bacterial foci [10]. Unfor-
tunately, such interventions are invasive, can be painful,
and are likely to prolong a child’s visit to the ED, con-
tributing to extended ED waiting times and driving the
use of scarce ED healthcare resources.
The test currently providing the greatest degree of cer-
tainty in diagnosing invasive bacterial infections, the blood
culture, typically takes 12–48 h to provide results, has a
sensitivity of just 30–40% [11], and a significant false posi-
tive rate due to contamination with commensal bacteria
from the skin and mucosal surfaces [12]. This limits the
diagnostic utility of the blood culture to clinicians re-
quired to make decisions concerning the management of
the febrile child in real time, which in turn increases the
importance of sufficient observation time, blood/urine in-
vestigations, and clinical judgement.
With the potential over-treatment of febrile children on
the one hand and the prospect of failing to identify poten-
tially life-threatening SBIs on the other, a lack of timely and
reliable indicators of febrile aetiology, coupled with a nat-
ural tendency for risk aversion when treating children, has
resulted in a substantial financial burden to healthcare sys-
tems worldwide. However, to date, just a handful of studies,
predominantly USA based and conducted between 6 and
25 years ago in young children, have examined the eco-
nomic impact of paediatric febrile illness [13–16].
Using a bottom-up time-driven and activity-based costing
model (TDABC), the aims of this research were to (1) esti-
mate the economic impact of managing febrile illness epi-
sodes in children of all ages and presenting complaints, in
an NHS paediatric ED setting; (2) identify how manage-
ment practices and costs vary with factors including patient
age, and the experience of treating clinicians; and (3) pro-
vide insights regarding where any diagnostic advances cur-
rently under development, including molecular diagnostics,
protein biomarkers, and point-of-care (POC) testing tech-
nologies, are likely to yield the greatest clinical and socio-
economic value, by reducing clinical uncertainty increasing
confidence to withhold antibiotics.
Methods
Participants and methods
This study applies time-driven activity-based costing
(TDABC), a bottom-up approach to healthcare costing,
which maps pathways observed during routine clinical
practice, identifies all points and durations of interaction
therein, and assigns time-dependent costs to each constitu-
ent. The costs of non-time-dependent activities, including
tariff-based ancillary investigations, are subsequently added
to provide a representative activity-weighted cost per com-
pleted treatment episode.
A total of 8552 consecutive febrile children, with a
temperature above 38 °C at presentation or below 38 °C
with an unverified parent-reported history of fever up to
3 days previous, were prospectively identified. All children
visited Alder Hey Children’s NHS Foundation Trust, a
large paediatric specialist care provider in the North West
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of England, between 1 September 2012 and 31 August
2013. Children were excluded (1) if data concerning key
components of their stay, including the treatments pro-
vided, or healthcare personnel seen, were missing or
incomplete or (2) if there were pre-existing medical
conditions likely to modify ED care pathways from
those of the average ‘otherwise well’ patient, including
paediatric oncology patients.
A schematic of the clinical pathway used for this study
is provided in Fig. 1. Children were initially seen by a
qualified ED nurse who conducted an initial evaluation,
using the Manchester Triage System (MTS) [17]. MTS
assessments follow a flow chart based on the patient’s
reason for contacting the ED. The chart begins by iden-
tifying possible criteria indicating life-threatening condi-
tions for the patient, and if none of these conditions are
present, the nurse continues along the flow chart asking
questions until the nurse assigns the patient an appro-
priate category. The nurse’s experience can contribute to
the assessment, but on the other hand, the risk of the
nurse missing serious conditions is reduced because the
flow chart forces the nurse to ask key questions and
make vital inquiries. Children were triaged as green
‘standard’, yellow ‘urgent’, orange ‘very urgent’, or red ‘imme-
diate attention’. For several children, borderline ‘yellow/red’
or ‘orange/red’ categories were applied. This was a result of
uncertainty during triage, and such children had their MTS
classification amended with increased or reduced urgency
following a second opinion with a nurse or clinician. Diag-
nostic categories, defined as definite bacterial, probable bac-
terial or bacterial syndrome with low/no inflammatory
markers, definite viral, probable viral, or viral syndrome
with no/high inflammatory markers, trivial illness, inflam-
matory illness, and unknown/insufficient information, were
applied retrospectively, based on an adapted algorithm
from Herberg et al. [18]. In any instance where uncertainty
or disagreement occurred regarding the appropriate classifi-
cation, these cases were marked and decided upon by two
consultants specialising in paediatric infectious disease. All
cases had notes, including CRP, neutrophils, and sterile site
pathogenic bacteria recorded such that diagnosis classifica-
tions could be quality checked, to ensure consistency. For
this analysis, definite bacterial, probable bacterial and bac-
terial syndromes with low/no inflammatory markers, were
collectively defined as ‘bacterial aetiologies’, while definite
viral, probable viral, and viral syndromes with no/high
inflammatory markers were collectively defined as ‘viral
aetiologies’. Like other studies [19], the prescription of anti-
biotics for patients with anything other than a bacterial aeti-
ology of fever was, for this study, defined retrospectively as
‘potentially avoidable’.
Because time stamps documenting the duration of
contact with healthcare personnel for various treatments
and investigations are not routinely collected as part of
NHS electronic patient records, these were imputed in
one of two ways. Firstly, estimates were provided by staff
actively involved in the provision of ED care. Secondly,
prospective time-in-motion data were collected for a
representative cohort of 71 febrile children presenting to
Alder Hey Children’s NHS Foundation Trust ED between
January 6 and February 12, 2017. Four 5th-year medical
students collected the data by ‘shadowing’ patients report-
ing to the book-in desk with fever as a symptom. Addition-
ally, any patients suspected of fever by clinical teams (such
as the nurse performing an initial visual assessment) were
additionally identified. The researchers followed patients
through the ED, documenting all points of interaction
with healthcare professionals using a stopwatch and a
pre-designed case report form. Data were collected in
four hourly blocks during the day (8 a.m.–4 p.m.),
evening (4 p.m.–12 a.m.), and early morning (12 a.m.–4
a.m.), 7 days a week. All children with a suspected fever
were observed from the point of visual assessment, and
their experience in the ED, timed using a stopwatch
and documented in Microsoft® Excel. For any events
which were not observed during implementation of the
Fig. 1 Clinical pathway of paediatric febrile illness used for patient-level costing
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time-in-motion study, including clerical and administrative
tasks such as writing up patient notes, these were estimated
following a Delphi panel approach. In all such cases, a
number of estimates were obtained and the average time
was used because tasks, such as inserting a cannula for
example, can be expected to take varying lengths of time
depending upon factors such as experience, co-operation of
the child, state of hydration, or vascular filling. All timings
used are provided in Table 1.
Unit costs
Hourly salaries for healthcare personnel were provided
by the patient-level costing department at the Trust.
Except for clinicians, salaries for those working either
(1) at the weekdays between 7 p.m. and 7 a.m. or (2) at
the weekend had their hourly rate increased in line with
NHS guidance on working unsocial hours [20]. Costs for
non-time-driven activities, including laboratory-based in-
vestigations, were obtained from the Trust’s finance de-
partment and NHS reference costs 2015/16 [21].
Pharmaceuticals were assigned unit costs from the British
National Formulary. As data concerning the precise antibi-
otics provided to patients were not available, we assumed
that antibiotic prescribing was in line with the recom-
mendations provided within NICE CG160 [22]. Namely,
where intravenous (IV) antibiotics were prescribed, both a
third-generation cephalosporin (cefotaxime, ceftriaxone)
and an anti-listeria agent were provided (amoxicillin, ampi-
cillin) for infants under 1month, and a third-generation
cephalosporin alone if more than 1month. In cases of
empiric IV antibiotic therapy, it was assumed that a third-
generation cephalosporin directed against Neisseria
meningitidis, Streptococcus pneumoniae, Escherichia
coli, Staphylococcus aureus, and Haemophilus influenzae
type b was provided. Where oral antibiotics were pre-
scribed, it was assumed that amoxicillin or cephalexin was
provided as per local antimicrobial guidance.
Costs incurred during inpatient stay were obtained from
NHS reference costs 2015/16. The tariff HRG PW20C
(paediatric fever of unknown origin, CC score = 0) was
utilised to reflect a 3-day short stay inpatient admission.
As children could be admitted for anywhere between 1
and 72 h under the reference tariff, this figure was divided
through by 72 and multiplied by the number of hours of
inpatient admission. Patients who exceeded the 3-day
limit incurred an excess bed day charge which was applied
from the fourth day until discharge [21]. Finally, indirect
costs were estimated for each patient, using the ‘full
absorption approach’. This included the anticipated use of
facilities, such as toilets, and the time of administrative
staff typing up and sending discharge notes to the patient’s
general practitioners. Societal costs, including parental
absence from work, and children’s absence from school
were not included, as the analysis was conducted from a
healthcare provider perspective. Due to the short time
frame of the analysis, costs were not discounted. All unit
costs were in 2017 prices and are provided within Table 2.
Outcomes and statistical analysis
We present summary statistics to describe the characteris-
tics of participants. Categorical variables were summarised
by frequency and percentage, while continuous variables
were reported as mean, standard deviation (SD), median,
interquartile range (IQR), and minimum and maximum
values. Our primary outcome was the ‘cost per completed
febrile illness episode’, with an ‘episode’ defined as the
period from booking in to the ED to final discharge, enab-
ling the possibility for re-attendances to be included. We
additionally performed sub-group analyses to account for
patient and healthcare provider heterogeneity. As our pri-
mary outcome data were both non-normally distributed,
and characterised by sub-groups of unequal size, the
Kruskal-Wallis test was applied to assess statistical signifi-
cance, with Dunn’s post hoc pairwise comparison (ad-
justed by the Holm FWER method) used to determine
where significant differences were present. Results were
reported as p values and considered statistically significant
at the standard 5% level. Multivariate regression analysis
using a generalised linear model (GLM) was performed to
estimate conditional mean health expenditure and identify
covariates associated with increased healthcare utilisation.
Because several prior studies have demonstrated that the
gamma family with a log error link is not only robust, but
also the most commonly applied approach in healthcare
cohorts in which positive and skewed healthcare costs are
Table 1 Staff time associated with components of the
paediatric febrile illness pathway
Activity Mean duration (min)
Triage time (nurse)* 4.5
Clinician consultation time (MTS green)* 16.2
Clinician consultation time (MTS yellow)* 19.4
Clinician consultation time (MTS orange)* 21.1
Clinician consultation time (MTS red)* 22.7
Clinician time—writing up patient notes# 10
Order blood/urine culture (clinician)# 10
Arrange X-ray (clinician)# 6
Book patient into the ED (receptionist)# 2
Refer patient to other specialties (clinician)# 20
Insert cannula (clinician)* 20
Provide antibiotics/other medicines (nurse)# 5
Visual assessment triage (nurse)* 2
Interpret results of ancillary investigations
(clinician)#
10
*Collected during time-in-motion study
#Estimate provided by ED consultants
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guaranteed [23, 24], our analysis also assumed a gamma
error distribution with log link.
Finally, because all timings employed within the
TDABC were estimates, and therefore subject to one or
more of (1) sampling bias, (2) Hawthorne effects, or (3)
reporting bias, a distribution of credible times for each
patient interaction with healthcare personnel was used
in the time-driven and activity-based costing, to reflect
the uncertainty inherent to sampling. For all parameters
contained within the time-driven and activity-based
costing, continuous variables (time in consultation with
clinician, days spent as inpatient) were randomly sam-
pled from gamma distributions as explained by Briggs
[25]. Dichotomous variables (percentage of triage assess-
ments performed by band 5/6 nurses) were sampled
from representative beta distributions constructed from
the sample data available, as explained in previous work
by Briggs et al. [26]. For estimates reliant on expert
Table 2 Unit costs by component of paediatric febrile illness
pathway
Item Unit cost
Investigations (per test)
Amylase £6.00
Bacterial PCR £158.00
Bilirubin £6.00
Biochemistry profile £8.00
Blood albumin £6.00
Blood glucose test £6.00
Blood culture £35.00
Blood gas# £7.00
Blood taken £3.00
Calcium profile £7.00
Clotting screen £5.00
Creatinine £6.00
CRP £6.00
CSF £6.00
CT scan (head) £201.00
ECG £33.00
ENT swab £19.00
ESR £4.00
FBC £3.00
Glandular fever screen £4.00
Group and save £12.00
LFTs £7.00
Magnesium £6.00
Malarial parasite test £21.00
Measles PCR £55.00
Meningo pneumo PCR £25.00
Meningococci screen £6.00
Mycoplasma SER £23.00
Pertussis swab £9.00
Phosphate £6.00
Rapid Strep test £9.00
Renal profile £46.00
Respiratory PCR £117.00
RSV screen £12.00
Ultrasound £55.00
Urinalysis# £8.00
Urine albumin £6.00
Urine culture# £8.00
Urine dipstick# £6.00
Urine sample £8.53
Virus PCR £56.00
X-ray £46.00
Table 2 Unit costs by component of paediatric febrile illness
pathway (Continued)
Item Unit cost
Antibiotics (per dose/course)
Amoxicillin 125 mg (suspended)* £1.16
Amoxicillin 125 mg (IV)* £4.34
Amoxicillin 250 mg (susp.)* £1.33
Cefotaxime 195mg (IV)* £0.48
Cefotaxime 575mg (IV)* £0.66
Nurse time (per hour)
Band 5 £15.43
Band 6 £18.95
Band 7 £22.50
Band 8a £27.39
Doctor time (per hour)
FY1/FY2 £24.24
ST1-3 £30.79
APNP £27.39
Registrar £39.02
Consultant £76.11
Referral to other specialties
Surgery £178.55
Medicine £272.74
ENT £146.92
Neuro £411.78
Inpatient admission
Short stay (HRG PW20C, 3 days non-elective stay)# £1712
Excess bed day charge# £462
Unit costs provided by Alder Hey Finance Team unless otherwise stated
#NHS Reference costs 2016
*British National Formulary 2017
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opinion, which were not observed during the time-in--
motion study due to a low frequency of occurrence, uni-
form distributions were sampled in the absence of
information concerning the true sample mean and vari-
ance. In choosing this distribution, we combined and
ranked response data from all healthcare professionals
(of varying roles and experience) surveyed, to define
lower and upper limits or ‘bounding’ criterion. Once re-
sponses were provided, respondents were informed of
responses by other respondents to gauge their belief in
the credibility of different responses and ensure that the
distributions utilised were plausible. GLM regression
modelling was subsequently replicated for 100 boot-
strapped costing datasets randomly utilising parameter
values from all plausible distributions, for all variables,
to assess the sensitivity of the primary outcome, the
cost per febrile illness episode, and the resulting GLM
coefficients, to changes in the values of underlying in-
put parameters. Details of all distributions utilised are
provided in Table 3. All analyses were performed using
STATA 14 (StataCorp LP, USA) and Microsoft® Excel™
(Redmond, WA).
Results
Descriptive statistics
Eight thousand five hundred fifty-two individual ED at-
tendances were identified over the study period, with
2034 excluded from the analysis due to incomplete data
or failing to meet our inclusion criteria. This resulted in
a complete dataset of 6518 observations (Table 4). There
was no significant difference in observable characteris-
tics between those included and excluded, including but
not limited to age, final diagnoses, MTS classification,
and temperature.
The mean (median) age of children included was 3.28
(2.17) years, with 53.5% male and 46.5% female. At pres-
entation, 47.52% of children were triaged as green ‘low
risk’ cases using the Manchester Triage System (MTS)
[17], 8.88% as yellow, 0.17% as yellow/red, 17.06% as
orange, 23.03% as orange/red, and 0.39% as red (high
risk). MTS classifications were not recorded in 2.9% of
patients. Most patients (66.32%) were treated by spe-
cialty doctors (ST1-3), followed by registrars or ST4–8
(22.05%), consultants (7.99%), APNPs (2.73%), and Foun-
dation year 1 and 2 doctors (0.91%). The mean (median)
time was 15.3 (14.7 min) between booking and triage, 67.9
(52 min) between triage and clinical consultation, and
68.4 (70.6 min) between consultation and discharge. Total
mean (median) time in the ED was 151.6 min (81.3 min).
Approximately 6.46% of patients were admitted as inpa-
tients, 1.42% of which for a single day, 29.78% 2 days,
21.51% 3 days, and 47.28% > 4 days.
Determinants of patient-level costs
Table 5 provides details of patient-level resource use and
costing. Those aged 0–3months exhibited a mean treat-
ment cost of £1000.28, [95% CI £82.89–£2993.37], over six-
fold higher than the least costly group, aged 3–6 years,
(£158.97 [95% CI £20.43–£1596.43]). Use of blood cultures
(p = 0.0312), urine samples, inpatient admission rates, and
inpatient length of stay (p = 0.0001) were all statistically sig-
nificantly increased for those aged 0–3months, versus all
other age groups, as shown in Table 6.
The distribution of MTS classifications was approxi-
mately equal across all age groups, except for those aged
0–3 months, 74.41% of which were triaged as yellow or
higher. As expected, overall healthcare expenditure in-
creased with increasing MTS severity, from £121.78 per
patient (green), £424.43 (yellow), £487.16 (orange), and
£549.42 (red), the majority of which as a direct result of
increasing rates of inpatient admission. A one-step in-
crease in triage category, from green to yellow, resulted
in a 422% increase in inpatient admission, a 19.6% in-
crease in length of stay for those admitted, and a 391%
increase in use of blood cultures. In terms of final diag-
noses, bacterial infections were most commonly ob-
served in those aged 0–3 months (15.5%), 3–6 months
Table 3 Distributions used for probabilistic sensitivity analysis
Parameter Distribution
Time (hours)
Nurse triage Gamma (4.69, 0.01)
Proportion performed by band 6 nurses Beta (16, 55)
Proportion performed by band 5 nurses 1-Beta (16, 55)
Clinical consultation Gamma (3.9, 0.04)
Clinician writing up patient notes Uniform (1, 20)
Arrange blood/urine culture Uniform (1, 25)
Arranging X-ray Uniform (1, 30)
Receptionist booking patient in Uniform (1, 5)
Clinician arranging referral Uniform (1, 25)
Clinician cannulating child Uniform (5, 35)
Nurse providing antibiotics to child Uniform (1, 10)
Visual assessment by nurse Uniform (0.5,5)
Days spent as inpatient (if admitted) Gamma (3.72, 1.03)
Salary (cost/hour)
Nurse (band 5) Uniform (13.36, 17.5)
Nurse (band 6) Uniform (16.14, 21.77)
Nurse (band 7) Uniform (19.34, 25.67)
Nurse (band 8a) Uniform (24.8, 29.99)
Foundation year doctor Uniform (22.5,26)
ST1-3 Uniform (27, 30.8)
APNP Uniform (24.8, 29.99)
Registrar Uniform (36, 41)
Consultant Uniform (64.8, 87.4)
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Table 4 Descriptive statistics of the study participants
Mean (SD) Median (IQR) Min Max
Age 3.28 (3.09) 2.17 (3.5) 4 days 15.98 years
Gender male (freq) 53.5% (3484) – – –
Temperature 38.7 (1.07) 38.6 (1.7) 35 41.4
Respiratory rate (bpm) 29.95 (9.23) 28 (8) 14 188
Pulse (bpm) 138.7 (25.98) 138 (37) 22 250
Manchester Triage Scale (MTS) classification
MTS green (freq) 47.52% (3097) – – –
MTS yellow (freq) 8.88% (579) – – –
MTS yellow/red (freq) 0.17% (11)
MTS orange (freq) 17.06% (1112) – – –
MTS orange/red (freq) 23.03% (1501)
MTS red (freq) 0.39% (27) – – –
MTS not recorded (freq) 2.9% (191) – – –
Timings
Time between booking and triage (min) 15.3 (14.7) 11 (18) 0 71
< 10 47.8%
11–20 24.1%
21–40 20%
41–60 5.6%
> 61 2.5%
Time between triage and consultation (min) 67.9 (52) 55 (65) 0 609
< 30 26.9%
31–60 27.7%
61–120 30.8%
121–180 11.4%
181–240 2.6%
> 240 0.6%
Time in ED post consultation (min) 68.4 (70.6) 45 (72) 0 630
< 30 43.5%
30–60 15.1%
61–120 24.8%
121–180 9.7%
> 181 7%
Total time in ED (min) 151.6 (81.3) 135 (98) 16 729
< 60 8.3%
61–120 32.7%
121–240 46.9%
241–360 9.6%
> 361 2.5%
Inpatient length of stay (days)
Not hospitalised 93.51%
1–3 3.42%
4–7 2.43%
8+ 0.63%
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(11.03%), and 10–16 years (11.74%); however, the only
significant difference was when comparing these groups
to those aged 1–3 years (4.6%), p < 0.05. Those with bacter-
ial aetiologies of fever exhibited over threefold higher man-
agement costs than those with viral aetiologies (£988.19 vs.
£294.52).
Antibiotic prescribing patterns
Approximately 32.4% of febrile children were prescribed
antibiotics, of whom 7.05% were retrospectively diag-
nosed with bacterial aetiologies of fever. Approximately
14.9% of patients were retrospectively classified as hav-
ing inflammatory, 10.8% as trivial, and 6.6% as viral aeti-
ologies of fever (probable, definite and viral syndromes)
were prescribed potentially avoidable antibiotics, if a
means of distinguishing these from bacterial causes of
infection has been available (Table 7). Analysing children
with viral causes of fever who were triaged as MTS
green or yellow (those not deemed to require very
urgent or immediate care), those receiving antibiotics
spent an additional 53.9 h as inpatients (57.1 vs. 3.2 h)
compared to children with viral aetiologies of fever,
triaged MTS green or yellow, who were not prescribed
antibiotics. This resulted in a 9.9-fold increase in
management costs for those who received potentially
avoidable antibiotics (£1392.30 vs. £140.10) as shown in
Table 8, the majority of which attributable to the costs
of inpatient or short stay beds for observation.
Determinants of increased healthcare expenditure during
paediatric febrile episodes
Based on generalised linear modelling, compared to the
reference group of those aged 1–3 years, those aged 0–3
months experienced a 3.54-fold [95% CI 2.59–4.85-fold,
p < 0.0001] increase in healthcare resource use. The
presence of a NICE NG51 respiratory rate red flag [27]
increased costs by 72.1% (p < 0.0001) (Table 6). Other
factors associated with increased resource use included
treatment by Foundation year 1/Foundation year 2 (FY1/
FY2) doctors, which were increased 3.19-fold, relative to
the consultant reference group, p < 0.0001. When consid-
ering only non-urgent children, triaged as green using the
MTS, FY1/FY2 doctors exhibited a 7.98-fold increase in
costs of management, relative to consultants (p < 0.0001).
FY1/FY2 doctors recorded the highest rates of inpatient
admission, ancillary investigations, and referring children
to other specialties. Comparing resource use for FY1/FY2
doctors working out of hours and those working during
regular hours, where the availability of ancillary investiga-
tions may be reduced, there was no significant difference
(p = 0.9626). Factors including male gender and being
treated by an APNP were shown to reduce costs by 15.1%
(p = 0.0241) and 42.7% (p = 0.0112) respectively, as shown
in Table 9.
Increasing clinical severity, as proxied by increasing
MTS classifications, resulted in significant cost increases
of 138.2% (2.38-fold), 185.7% (2.85 fold), and 199.2%
(2.99-fold) respectively compared to children triaged as
green (all p < 0.01). As such, we performed independent
GLM regressions for three MTS groups (green, yellow,
and orange/red), to account for the possibility that severity
of illness may have an important role in determining overall
resource use. Similar to the results when pooling children
of all severities, those demonstrated in Fig. 2 highlight the
consistent importance of ages (< 6months, 10–16 years),
prompting a NICE respiratory rate red flag [27], and being
treated by an FY1 or FY2 doctor, suggesting that these are
key drivers of increased resource use when managing paedi-
atric febrile illness after taking clinical severity into account.
Sensitivity analysis
Our findings were insensitive to changes in the values of our
input parameters. Following the Monte Carlo simulation
and re-running our generalised linear models on 100 boot-
strapped datasets, the coefficients listed in Table 10 were ob-
tained. Children triaged as MTS yellow or above, those
prompting a NICE NG51 respiratory rate red flag, and those
treated by an FY1/FY2 doctor, and treatment of children
Table 4 Descriptive statistics of the study participants (Continued)
Mean (SD) Median (IQR) Min Max
Re-attendance (freq) 3.43% (224) – – –
Afterhours (freq) 88.9% (5798) – – –
Winter (freq) 60.1% (3918) – – –
Reviewing clinician
APNP 2.73% (178) – – –
Consultant 7.99% (521) – – –
Foundation years 1 and 2 0.91% (59) – – –
Registrar 22.05% (1437) – – –
ST1-3 66.32% (4323)
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aged 0–3months, 3–6months, or 10–16 years respectively,
were statistically significant predictors of increased health-
care costs in 100% of simulations. Conversely, the cost
savings associated with male gender and treatment by an
APNP remained significant in just 8% and 28.3% of simula-
tions respectively.
Table 5 Health service costs of paediatric febrile illness by sub-group
Number Mean Std. dev 95% CI Median IQR p value*
Age
0–3 months 129 £1000.28 £1469.98 £82.39–£2993.37 £76.65 £1834.10
3–6 months 281 £522.33 £1737.66 £122.08–£2123.51 £53.63 £55.70
6–12 months 1041 £205.28 £585.18 £28.26–£734.39 £51.29 £21.50
1–3 years 2498 £190.44 £594.95 £13.22–£643.89 £51.64 £21.60
3–6 years 1547 £158.97 £501.82 £20.43–£1596.43 £51.29 £19.80 p = 0.0001
6–10 years 707 £165.92 £485.04 £11.14–£843.02 £52.98 £20.70
10–16 years 315 £408.32 £1030.12 £44.97–£2188.27 £55.55 £40.90
Gender
Male 3482 £210.17 £600.23 £38.45–£818.68 £51.29 £21.50
Female 3036 £238.90 £835.77 £14.13–£924.63 £53.16 £23.10 p = 0.0001
NICE NG51 heart rate red flag [27]
Yes 2797 £259.40 £848.10 £21.76–£1015.89 £54.03 £24.60 p = 0.0001
No 3721 £196.59 £604.38 £18.36–£699.74 £50.87 £20.30
NICE NG51 respiratory rate red flag [27]
Yes 394 £493.92 £1035.52 £89.16–£2011.32 £66.67 £70.45
No 6124 £206.15 £691.06 £23.71–£737.44 £51.29 £21.50 p = 0.0001
Clinical grade
APNP 178 £109.52 £312.67 £12.74–£741,65 £48.01 £21.80
Consultant 521 £315.13 £1344.91 £25.76–£1536.36 £73.23 £40.70 p = 0.0001
FY 1 and 2 59 £731.78 £913.38 £97.91–£1125.77 £327.98 £49.90
Registrar 1437 £255.40 £702.86 £19.40–£1045.91 £54.49 £23.80
ST1-3 4323 £199.68 £615.00 £12.51–£721.02 £49.77 £28.05
Afterhours
Yes 5798 £222.22 £726.36 £14.77–£776.64 £51.92 £22.40
No 720 £234.19 £664.61 £11.96–£913.33 £51.65 £22.00 p = 0.0018
MTS classification
Green 3098 £121.78 £390.33 £15.81 - £400.93 £49.43 £19.05
Yellow 579 £424.43 £1027.90 £340.69–£508.17 £63.10 £557.35
Yellow/red 10 £85.71 £95.24 £71.73–£99.42 £52.33 £16.50 p = 0.0001
Orange 1112 £487.16 £1209.15 £416.08–£558.24 £68.86 £77.05
Orange/red 1502 £152.13 £491.60 £123.44–£170.56 £51.84 £17.20
Red 26 £549.42 £813.99 £236.47–£862.35 £76.88 £1165.85
Not recorded 191 £292.01 £966.43 £154.93–£429.09 £50.87 £20.40
Final diagnosis
Bacterial infection/syndrome 460 £988.19 £1781.97 £86.89–£2971.08 £77.95 £1757.35
Viral infection/syndrome 1595 £294.52 £797.43 £18.92–£1082.33 £51.64 £24.25
Inflammatory infection/syndrome 74 £582.58 £1302.26 £37.60–£1516.05 £63.44 £1140.65 p = 0.0001
Other or trivial infection 130 £390.06 £786.27 £22.34–£1243.30 £64.04 £187.15
Unknown cause 4259 £103.06 £286.52 £12.40–633.87 £51.29 £18.60
*Kruskal-Wallis test
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Discussion
This study reports the largest comprehensive, prospect-
ive observational study to date, assessing the economic
implications of diagnostic uncertainty when managing
paediatric febrile illness, in those aged 0–16 years, in an
ED setting. In a full cohort analysis on the management
of this highly common condition, we demonstrate that
the healthcare resources required to manage this condi-
tion are both significant and subject to extensive vari-
ation, some of which can be explained by the presence
of certain patient and healthcare provider characteristics.
Infants aged 0–6 months (particularly those aged 0–3
months), those triaged as MTS yellow or above, and
those managed by lesser experienced clinicians (FY1 and
FY2) required significantly greater resources in the ED.
This was primarily a result of increases in observation
time for patients and inpatient length of stay, the latter
particularly prominent in those receiving antibiotics. In
cases of MTS green and yellow viral infections, where
antibiotics were potentially avoidable, provided more
sensitive and prompt diagnostics had been available at
this time, costs increased 9.9-fold (95% CI 6.48–
13.2-fold). This was equivalent to an additional £1352.20
spend per patient (all patients pooled), rising to £2363
for infants aged less than 3 months.
Our study had several strengths. We included more
than 6500 febrile children over all seasons during a
1-year period, and by applying TDABC methodology, we
could achieve significant detail regarding actual resource
use. This resulted in an inclusive and representative esti-
mate of the economic impact of paediatric febrile illness
to NHS EDs. Capturing model input data using a pro-
spective time-in-motion approach provided confidence
regarding the time requirements of essential compo-
nents of care in the patient pathway. Data regarding
these patient touchpoints are not currently available in
Table 6 Health service utilisation by patient age and MTS score
Inpatient Length of stay (days)# Any test Blood culture X-ray Urine sample Review by consultant
Age
0–3 months 34.11% 5.67 51.16% 28.70% 9.30% 39.53% 10.07%
3–6 months 15.66% 5.34 40.92% 11.03% 12.10% 32.74% 5.69%
6–12 months 6.34% 3.83 31.98% 2.01% 9.12% 23.24% 8.64%
1–3 years 5.36% 4.05 29.74% 2.52% 10.88% 18.37% 7.64%
3–6 years 4.01% 4.02 28.70% 3.03% 9.43% 13.70% 8.14%
6–10 years 4.53% 3.78 34.08% 3.67% 9.61% 17.25% 8.76%
10–16 years 7.96% 4.73 42.22% 8.88% 10.15% 15.87% 7.3%
p value 0.0001§ 0.0001* 0.0001§ 0.0001§ 0.5370§ 0.0001§ 0.1342§
MTS classification
Green 2.61% 3.88 24.59% 1.51% 5.68% 16.17% 8.06%
Yellow 13.64% 4.64 43.52% 7.42% 11.91% 23.48% 9.32%
Orange 17.27% 4.23 44.6% 10.07% 23.2% 19.15% 8.45%
Red 30.77% 2.63 26.92% 15.38% 11.53% 11.53% 23.07%
p value 0.0001§ 0.0001# 0.0001§ 0.0001§ 0.0001§ 0.0023§
#Mean length of stay among those admitted for at least 1 day
*Kruskal-Wallis test
§Chi-squared test
Table 7 Antibiotic prescribing rates differentiated by age and final diagnosis
Receiving antibiotics
Total
(%)
0–3 months
(%)
3–6 months
(%)
6–12 months
(%)
1–3 years
(%)
3–6 years
(%)
6–10 years
(%)
10–16 years
(%)
p value#
All 32.4 27.9 24.2 24 31.9 37 34.5 40.3 0.0001
Bacterial 89.6 85 96.8 84.3 93 89 87.7 91.9 0.3610
Viral 6.6 20.8 10 3.2 9.4 4 2.60 5.7 0.0001
Inflammatory 14.9 0 0 0 9.5 17.2 23.1 12.5 0.9330
Trivial 10.8 0 50 0 9.7 8.1 20 5.3 0.0820
Unknown 36.4 17.3 19.2 25.5 35.7 43.3 42.2 48.1 0.0001
#Chi-squared test
Leigh et al. BMC Medicine           (2019) 17:48 Page 10 of 15
published literature, and we believe this analysis has
filled a gap which may subsequently be used for similar
health economic analyses in the future.
Limitations of our study include the fact that pre-
sumed viral and bacterial aetiologies of fever were ap-
plied retrospectively; therefore, we lacked the benefit of
clinical acumen and parental anxiety which could heavily
influence the decision to prescribe antibiotics. While we
made every effort to minimise bias when coding final
diagnoses using the algorithm provided by Herberg et al.
[18], there is a possibility that errors could have oc-
curred, which may have affected conclusions regarding
potentially avoidable antibiotics in the event of an incor-
rect diagnosis. However, following random sampling and
checking of diagnoses, we believe the likelihood of this
to be minimal given the level of detail provided and sim-
plicity in using the diagnosis algorithm. Another poten-
tial limitation is the completeness of the dataset, with
just under 24% of observations removed due to missing
or incomplete data. While it was assumed that these
Table 8 Treatment costs differentiated by age, final diagnosis, and antibiotic status
Viral Trivial Inflammatory Bacterial
Antibiotics given? Yes No Yes No Yes No Yes No
All* £1392.30 £140.10 £324.49 £224.54 £185.08 £669.86 £755.03 £747.43
0–3 months £2842.60 £479.65 N/A £113.81 N/A £50.87 £2476.96 £2419.07
3–6 months £1969.38 £142.81 £50.39 £334.50 N/A £65.92 £1078.39 £60.78
6–12months £2452.83 £159.57 N/A £58.63 N/A N/A £376.20 £774.53
1–3 years £687.02 £151.09 £2223.43 £256.88 £51.43 £390.81 £883.52 £278.09
3–6 years £1201.76 £123.97 £58.69 £196.88 £54.52 £355.06 £450.45 £586.77
6–10 years £1575.80 £63.65 £51.46 £87.65 £475.93 £447.47 £416.84 £672.95
10–16 years £2603.54 £143.37 N/A £401.88 £101.95 £4842.32 £1484.10 £694.91
*MTS green and yellow only
Table 9 Determinants of healthcare resource use for paediatric febrile episodes
Coefficient Ln(β) Exp (β) 95% CI (β) low 95% CI (β) high p value
0–3 months 1.265 3.543 2.589 4.85 0.001
3–6 months 0.791 2.207 1.544 3.155 0.001
6–12months 0.171 1.186 0.924 1.524 0.180
3–6 years − 0.164 0.848 0.705 1.021 0.082
6–10 years − 0.046 0.954 0.738 1.235 0.724
10–16 years 0.656 1.927 1.399 2.654 0.001
Gender (male) − 0.163 0.849 0.736 0.978 0.024
Time from book-in to triage − 0.005 0.994 0.990 0.999 0.013
NICE HR 0.034 1.034 0.894 1.197 0.644
NICE RR 0.543 1.721 1.289 2.299 0.001
Time from triage to call in − 0.001 0.999 0.997 1.000 0.357
APNP − 0.555 0.573 0.374 0.878 0.011
FY1/FY2 1.161 3.193 2.017 5.055 0.001
ST1-3 − 0.161 0.851 0.670 1.081 0.187
Registrar − 0.068 0.933 0.719 1.212 0.608
After hours** 0.147 1.159 0.867 1.548 0.317
Winter − 0.215 0.806 0.695 0.934 0.004
MTS yellow 0.868 2.382 1.905 2.979 0.001
MTS orange 1.049 2.857 2.397 3.405 0.001
MTS red 1.096 2.992 1.762 5.081 0.001
#Figures are exponentiated GLM (gamma, log) coefficients, interpreted as x-fold increases versus the reference group
*Reference group age = 1–3 years, reference group clinical grade = consultants, reference group MTS classification = green
**Between the hours of 6.30 p.m. and 8 a.m. Monday to Friday, and all-day Saturday, Sunday, and bank holidays
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data were missing at random, we cannot be sure of this,
and as such, we are unsure how the results may have dif-
fered if data for these 2034 children were available. While
we made every effort to ensure a thorough approach to cap-
turing NHS resource use, there were also instances where
we likely underestimated costs. Our time-in-motion data
did not capture information regarding additional consulta-
tions and advice from senior members of staff, which are
likely to increase the costs of lesser experienced clinicians
managing febrile children, nor did it include the societal
costs of febrile illness borne by parents, including time off
work, especially in the case of hospitalisation. Considering
that new diagnostics may result in a reduction in antibiotic
use, it is plausible that re-attendances or time observing pa-
tients in the department could increase, thereby potentially
reducing the value to parents of improved diagnostics. The
final limitation of our study concerns the generalizability of
the findings to other settings, whether in the UK, Europe, or
further afield. Our data were collected from a single site,
and our analysis based on local prescribing protocols, as
such, the economic value of improving the management of
febrile illness in other settings, including the USA, where
are a more consultant-led approach may be more common,
may differ from those demonstrated here.
Two previous studies have reported healthcare costs for
managing children with SBIs, namely UTI [13] and men-
ingitis [14]. Two studies reporting costs of management
for children with fever of any cause [15, 16] have been per-
formed in the USA, with data collected at least 5 years
ago, in children aged < 3 years and < 90 days respectively,
thereby limiting their generalisability. Additionally, one
study conducted in Switzerland demonstrates the cost of
illness associated with paediatric community-acquired
pneumonia in 2010 [28]. However, no study prior to ours
has assessed the resource implications of managing fever
in a broad and representative cohort of all ages, diagnoses,
and types of resource use in Europe.
The finding that infants (particularly those aged < 3
months) tended to require significantly greater ED re-
sources may be explained by increased cautiousness and a
lack of symptomatic information directly from the children
themselves, when managing febrile infants. Despite most
causes of fever in children being self-limiting, the fear of
missing life-threatening infection in children with fever
remains a persistent problem for clinicians, who have a
natural tendency to be risk averse [29]. Commonly re-
ported concerns among clinicians treating febrile children
include suspected central nervous system damage (24%),
seizures (19%), and death (5%) [30], manifesting in overly
aggressive, and often, in hindsight, unnecessary treatment
[31]. Additionally, the prevalence of invasive bacterial in-
fections, bacteraemia and bacterial meningitis, is highest in
the first 3months of life, driving clinician behaviour to-
wards a cautious approach in this high-risk group. Clinical
Fig. 2 Determinants of healthcare resource use among febrile children of differing clinical risk/urgency
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prediction rules, such as the Yale observation scale may be
useful in these groups, particularly among those with less
experience in ruling in/out serious bacterial infections;
however, reliability in higher [32] vs. lower income coun-
tries [33] is variable, suggesting that these alone may not
be enough to fill the diagnostic gap faced by the clinician
managing paediatric febrile illness [34].
Though potentially avoidable antibiotic prescribing was
lower in our cohort (6.6% viral, 10.8% trivial illness) than
in similar studies based in the USA (36%) [35] and Oxford,
England (34%) [36], we found that antibiotic prescribing
for those with viral causes of fever was highest in those
aged 0–3 (20.8%), and 3–6months (10%) supporting our
finding of an increased tendency to be cautious when
treating young febrile infants. This resulted in not only a
substantial increase in ED resource use, but also likely
increased inconvenience and distress to the children and
parents involved, due to potentially unnecessary investiga-
tions and treatment. Furthermore, excess use of antibiotics
is known to contribute to increasing rates of antimicrobial
resistance (AMR) [37], an important component of both
the clinical and economic impact of AB prescribing which
we were unable to quantify in this analysis.
Given the paucity of published evidence, additional
research examining the patient-centred and societal impli-
cations of current diagnosis and treatment practices when
managing the febrile child would add considerable value
for those looking to determine the true value of improved
diagnostics, which may be capable of better targeting of
scarce ED resources. Given the variable performance and
accuracy of the MTS triage system in paediatric popula-
tions, we believe our finding that costs increased with MTS
severity is noteworthy. Recent large-scale validation studies
have highlighted the low reliability of the MTS in both
younger [17] and older children presenting to the ED with
fever [38], with an estimated 54% of children over-triaged
when using the MTS [34]. In adult studies, over-triaging by
just a single category, from green to yellow, has been shown
to increase the use of electrocardiogram (ECG) and labora-
tory investigations by 261% and 148% respectively [39].
Similarly, in our study, children triaged as yellow experi-
enced a 422% increase in inpatient stay, a 76.9% increase in
ancillary investigations, and a 15.6% increase in review by
consultants, versus those triaged as green. As the MTS cat-
egories yellow, orange, and red represent urgent, very ur-
gent, and immediate attention respectively, these are the
Table 10 Sensitivity analyses of determinants of healthcare costs for paediatric febrile episodes
β (base-case)# β (bootstrapped) Minimum β (% lower)# Maximum β (% higher)# Statistically significant* (%)
0–3 months 3.543 3.11 2.16 (39.02%) 3.92 (10.69%) 100
0–6 months 2.207 2.08 1.45 (34.39%) 2.68 (21.55%) 100
6–12months 1.186 1.27 1.00 (15.75%) 1.54 (29.84%) 38.38
3–6 years 0.848 0.88 0.68 (19.3%) 0.98 (15.77%) 19.19
6–10 years 0.954 1.00 0.74 (22.39%) 1.18 (23.63%) 0
10–16 years 1.927 1.81 1.25 (35.27%) 2.10 (8.98%) 100
Gender (male) 0.849 0.90 0.78 (7.91%) 0.99 (16.64%) 8.08
Time (book-in to triage) 0.994 1.00 0.99 (0.24%) 1.00 (0.65%) 16.16
NICE HR 1.034 1.03 0.89 (14.04%) 1.12 (8.75%) 0
NICE RR 1.721 1.65 1.19 (30.71%) 1.99 (15.60%) 100
Time (triage to call in) 0.999 1.00 1.00 (0.14%) 1.00 (0.13%) 3.03
APNP 0.573 0.69 0.37 (36.23%) 0.99 (72.91%) 28.28
FY1/FY2 3.193 3.29 1.98 (37.94%) 4.06 (27.11%) 100
ST1-3 0.851 0.90 0.72 (15.88%) 1.01 (18.17%) 0
REG 0.933 1.00 0.76 (19.02%) 1.12 (20.10%) 0
After hours 1.159 1.19 0.90 (21.98%) 1.47 (26.54%) 2.02
Winter 0.806 0.79 0.68 (15.08%) 0.89 (10.11%) 98.99
MTS yellow 2.382 2.27 1.77 (25.67%) 2.61 (9.59%) 100
MTS orange 2.857 2.89 2.23 (22.08%) 3.21 (12.43%) 100
MTS red 2.992 4.52 1.95 (34.80%) 6.87 (129.76%) 100
Constant 164.8 143.50 90.33 (45.19%) 179.37 (8.84%) 100
Reference group age = 1–3 years, reference group clinical grade = consultants, reference group MTS classification = green
#Figures are exponentiated GLM (gamma, log) coefficients, interpreted as x-fold increases versus the reference group
*Proportion of 100 bootstrapped GLM regressions in which p value was < 0.05
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groups with the highest probability of SBIs, we believe these
are the groups where novel diagnostics should be targeted.
While we found evidence of an increase in healthcare
utilisation among the least experienced clinicians (FY1/
FY2), just 0.9% of clinicians included in our study were
FY1 and FY2 doctors. The results observed in this sam-
ple were therefore highly susceptible to bias through a
lack of inter-clinician variability, and with a larger sam-
ple size may regress towards a lower mean. Additionally,
although GLM analyses highlighted a 44.2% increase in
time spent in the ED for those treated by FY1 and FY2
doctors when compared to consultants, this was likely
due to the need to seek second opinions from more ex-
perienced colleagues, something which we were unable
to attach costs to. This may also have been because lower
acuity patients wait the longest and are more likely to be
seen by lesser experienced doctors, as the sickest are
re-directed to senior doctors. Because it is likely that any
advances in diagnostics are likely to be heavily used by
lesser experienced doctors, this could reduce times in the
ED, but potentially still increase management costs. This
is particularly true if the price of novel POC tests is high,
as with multiplex PCR, which may cost the same as a day
in the hospital when first released. The price of such tests
can however be expected to decrease over time, resulting
in savings over the longer term.
Conclusions
In conclusion, based on a comprehensive and representative
sample of febrile children of varying age, presenting com-
plaints, final diagnoses, and treating clinicians, this study has
shown that the management of paediatric febrile illness in
the ED poses a substantial financial burden. This is predom-
inantly due to the impact of diagnostic uncertainty, which
most often leads to in increased observation time and in-
patient admission. Children aged 0–6months, those triaged
as MTS yellow and above, and those managed by newly
qualified doctors are the most likely to receive additional
resources in the ED. After accounting for the severity of ill-
ness, precautionary antibiotic prescribing, particularly in
younger low acuity children with viral illnesses, is associated
with substantial increases in health service utilisation, pre-
dominantly because of increases in inpatient admissions. So
far, information on potential shifts in infection epidemiology,
such as an increase in healthcare-associated infections or
reductions in vaccine-preventable infections or increases in
invasive disease due to serotype replacement, are unlikely to
affect our conclusions. Comparable settings in the UK and
elsewhere will likely show similar patterns in resource use.
Any advances in diagnostic capabilities, including molecular
diagnostics, protein biomarkers, and POC tests would likely
yield the potentially greatest efficiency gains in these groups
of children, as among these the perceived risks of untimely
diagnosis are greatest.
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